Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
At RSNA 2003, CAD vendors are rolling out expanded applications for current technologies, with more applications on the drawing board, notably in lung and colon applications.
To spark professional growth on the dynamics of digital technologies in healthcare in the 21st century, the Radiological Society of North America (RSNA) this year again presents infoRAD - informatics in radiology.
Higher sales of digital capture equipment, digital media and services for the revenue growth helped offset other segments for Eastman Kodak Co.'s Health Imaging division in the third quarter.
Philips Medical Systems demonstrated its works-in-progress advances for radiation oncology at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Salt Lake City this month.
CMS Inc. has received FDA 510(k) clearance for its I-Beam mobile patient positioning system that uses ultrasound and other images to locate target organs or tumors.
Siemens Medical Solutions will embed eResearch Technology Inc.'s (eRT) electronic clinical trial processing technology into Siemens information technology and operations platform.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
